68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report

被引：155
|
作者：
Rauscher, Isabel [1 ,2 ,3 ]
Maurer, Tobias [2 ,4 ]
Fendler, Wolfgang P. [2 ,5 ]
Sommer, Wieland H. [2 ,6 ]
Schwaiger, Markus [1 ,2 ,3 ]
Eiber, Matthias [1 ,2 ,3 ]
机构：
[1] Tech Univ Munich, Dept Nucl Med, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
[2] Clin Canc Ctr Munich CCM, Munich, Germany
[3] German Canc Consortium DKTK, Heidelberg, Germany
[4] Tech Univ Munich, Dept Urol, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
[5] Univ Munich, Dept Nucl Med, Marchioninistr 15, D-81377 Munich, Germany
[6] Univ Munich, Dept Clin Radiol, Grosshadern Campus,Marchioninistr 15, D-81377 Munich, Germany
来源：
CANCER IMAGING | 2016年 / 16卷
关键词：
Prostate cancer; Prostate specific membrane antigen; Positron emission tomography; GA-68-LABELED PSMA LIGAND; MEMBRANE ANTIGEN; BIOCHEMICAL RECURRENCE; RADICAL PROSTATECTOMY; LYMPH-NODES; HBED-CC; DIAGNOSIS; EXPRESSION; CARCINOMA; TOMOGRAPHY;
D O I：
10.1186/s40644-016-0072-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recently, positron emission tomography (PET) imaging using PSMA-ligands has gained high attention as a promising new radiotracer in patients with prostate cancer (PC). Several studies promise accurate staging of primary prostate cancer and restaging after biochemical recurrence with Ga-68-PSMA ligand Positron emission tomography/computed tomography (PET/CT). However, prospective trials and clinical guidelines for this new technique are still missing. Therefore, we summarized our experience with Ga-68-PSMA ligand PET/CT examinations in patients with primary PC and biochemical recurrence. It focuses on the technical and logistical aspects of Ga-68-PSMA ligand PET/CT examination as well as on the specific background for image reading discussing also potential pitfalls. Further, it includes relevant issues on free-text as well as structured reporting used in daily clinical routine.
引用
收藏
页数：10
相关论文
共 50 条
  • [31] Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions
    Fanti, Stefano
    Minozzi, Silvia
    Morigi, Joshua James
    Giesel, Frederik
    Ceci, Francesco
    Uprimny, Christian
    Hofman, Michael S.
    Eiber, Matthias
    Schwarzenbock, Sarah
    Castellucci, Paolo
    Bellisario, Cristina
    Chauvie, Stephane
    Bergesio, Fabrizio
    Emmett, Louise
    Haberkorn, Uwe
    Virgolini, Irene
    Schwaiger, Markus
    Hicks, Rodney J.
    Krause, Bernd J.
    Chiti, Arturo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (10) : 1622 - 1635
  • [32] 68Ga-PSMA PET/CT Detects the Location and Extent of Primary Prostate Cancer
    Fendler, Wolfgang P.
    Schmidt, Dorothea F.
    Wenter, Vera
    Thierfelder, Kolja M.
    Zach, Christian
    Stief, Christian
    Bartenstein, Peter
    Kirchner, Thomas
    Gildehaus, Franz J.
    Gratzke, Christian
    Faber, Claudius
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (11) : 1720 - 1725
  • [33] Evaluation of Predictors of Biochemical Recurrence in Prostate Cancer Patients, as Detected by 68Ga-PSMA PET/CT
    Christensen, Mads T.
    Jochumsen, Mads R.
    Klingenberg, Soren
    Sorensen, Karina D.
    Borre, Michael
    Bouchelouche, Kirsten
    DIAGNOSTICS, 2022, 12 (01)
  • [34] 68Ga-PSMA PET/CT in prostate cancer patients - patterns of disease, benign findings and pitfalls
    Keidar, Zohar
    Gill, Ronit
    Goshen, Elinor
    Israel, Ora
    Davidson, Tima
    Morgulis, Maryna
    Pirmisashvili, Natalia
    Ben-Haim, Simona
    CANCER IMAGING, 2018, 18
  • [35] Impact of 68Ga-PSMA PET/CT on Survival and Management in Prostate Cancer
    Algin, Efnan
    Okudan, Berna
    Acikgoz, Yusuf
    Sayan, Haluk
    Bal, Oznur
    Seven, Bedri
    CURRENT MEDICAL IMAGING, 2024, 20
  • [36] 68Ga-PSMA Uptake by Dermatofibroma in a Patient With Prostate Cancer
    Aydin, Funda
    Akcal, Arzu
    Unal, Betul
    Goksu, Sema Sezgin
    Gungor, Firat
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (05) : 358 - 360
  • [37] Will 68Ga-PSMA PET become the New Imaging Standard for Prostate Cancer?
    Duewel, C.
    Eiber, M.
    Maurer, T.
    AKTUELLE UROLOGIE, 2016, 47 (05) : 378 - 382
  • [38] Synchronous Paraganglioma Masquerading as 68Ga-PSMA PET/CT-Avid Metastasis in Carcinoma Prostate-How Specific Is 68Ga-PSMA PET/CT?
    Tyagi, Shantanu
    Singh, Shrawan Kumar
    Narain, Tushar Aditya
    Singh, Harmandeep
    Kumar, Rajender
    Vadi, Shelvin Kumar
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E420 - E422
  • [39] 68Ga-PSMA PET/CT in Patients With Biochemical Recurrence of Prostate Cancer: A Prospective, 2-Center Study
    Zacho, Helle D.
    Nielsen, Julie B.
    Dettmann, Katja
    Haberkorn, Uwe
    Langkilde, Niels C.
    Jensen, Jorgen B.
    Petersen, Lars J.
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (08) : 579 - 585
  • [40] 68Ga-PSMA PET thyroid incidentalomas
    Bertagna, Francesco
    Albano, Domenico
    Giovanella, Luca
    Bonacina, Mattia
    Durmo, Rexhep
    Giubbini, Raffaele
    Treglia, Giorgio
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2019, 18 (02): : 145 - 149
12345